JP2024543911A5 - - Google Patents

Info

Publication number
JP2024543911A5
JP2024543911A5 JP2024531252A JP2024531252A JP2024543911A5 JP 2024543911 A5 JP2024543911 A5 JP 2024543911A5 JP 2024531252 A JP2024531252 A JP 2024531252A JP 2024531252 A JP2024531252 A JP 2024531252A JP 2024543911 A5 JP2024543911 A5 JP 2024543911A5
Authority
JP
Japan
Prior art keywords
sequence number
seq
domain
sequence
variable light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531252A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543911A (ja
Filing date
Publication date
Priority claimed from GBGB2117111.1A external-priority patent/GB202117111D0/en
Application filed filed Critical
Publication of JP2024543911A publication Critical patent/JP2024543911A/ja
Publication of JP2024543911A5 publication Critical patent/JP2024543911A5/ja
Pending legal-status Critical Current

Links

JP2024531252A 2021-11-26 2022-11-25 細菌感染に対する治療薬として使用するための抗体 Pending JP2024543911A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2117111.1 2021-11-26
GBGB2117111.1A GB202117111D0 (en) 2021-11-26 2021-11-26 Antibodies for use as therapeutics against bacterial infections
PCT/EP2022/083353 WO2023094628A1 (en) 2021-11-26 2022-11-25 Antibodies for use as therapeutics against bacterial infections

Publications (2)

Publication Number Publication Date
JP2024543911A JP2024543911A (ja) 2024-11-26
JP2024543911A5 true JP2024543911A5 (https=) 2025-12-03

Family

ID=80038446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531252A Pending JP2024543911A (ja) 2021-11-26 2022-11-25 細菌感染に対する治療薬として使用するための抗体

Country Status (6)

Country Link
US (1) US20250026816A1 (https=)
EP (1) EP4436994A1 (https=)
JP (1) JP2024543911A (https=)
CN (1) CN118922440A (https=)
GB (1) GB202117111D0 (https=)
WO (1) WO2023094628A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121108335B (zh) * 2025-10-17 2026-03-27 广州医科大学附属第一医院(广州呼吸中心) 一种治疗溃疡性结肠炎的抗体及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880078A (en) 1987-06-29 1989-11-14 Honda Giken Kogyo Kabushiki Kaisha Exhaust muffler
CA2109528A1 (en) 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
US6121022A (en) 1995-04-14 2000-09-19 Genentech, Inc. Altered polypeptides with increased half-life
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
ATE508733T1 (de) 1996-03-04 2011-05-15 Penn State Res Found Materialien und verfahren zur steigerung der zellulären internalisierung
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
WO1999066903A2 (en) 1998-06-24 1999-12-29 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
CN112500489B (zh) * 2021-02-07 2021-05-04 天津一瑞生物科技股份有限公司 一种抗oxa-23型碳青霉烯酶杂交瘤细胞株,单克隆抗体及应用

Similar Documents

Publication Publication Date Title
JP2023549067A5 (https=)
RU2526517C2 (ru) Антитела против g-белка распираторно-синцитиального вируса (rsv)
JP6494519B2 (ja) 抗lpso11抗体
JP6278536B2 (ja) 関節炎治療
CN106456767A (zh) 多细菌感染的治疗
CN108473559A (zh) 特异性结合脂多糖的抗体分子-药物共轭物及其应用
KR20150094621A (ko) 스타필로코커스 아우레우스 표면 결정인자에 대한 항체
CN109689090B (zh) 抗o2抗体及其用途
CN116785427B (zh) 呼吸道合胞病毒特异性结合分子的用途
KR102748987B1 (ko) 사스-코로나바이러스-2에 특이적으로 결합하는 항체 및 그의 용도
CN112538112A (zh) 抗α-溶血素的抗体及其应用
CN118440191B (zh) 一种抗铜绿假单胞菌PcrV抗体的制备及其应用
CN118530352B (zh) 一种特异性识别铜绿假单胞菌PcrV的抗体及其应用
KR20190064636A (ko) 항-o1 항체 및 이의 용도
JP2024543911A5 (https=)
TW202214683A (zh) 結合b型肝炎病毒表面抗原的抗體及其應用
CN116178530A (zh) 抗体在治疗SARS-CoV-2感染的用途
JP2024511853A5 (https=)
CN120365418A (zh) 一种抗多血清型高毒力肺炎克雷伯菌的抗体及其用途
WO2025139807A1 (zh) K64型肺炎克雷伯菌荚膜多糖单克隆抗体、其杂交瘤细胞株及其应用
CN104797597A (zh) 针对胞壁肽的单克隆抗体
US20170038381A1 (en) Methods and compositions for identifying patient populations for diagnosis and treatment of tlr4-dependent disorders
CN113698478B (zh) 抗α-溶血素的抗体及其稳定制剂
JP2023509083A (ja) 腫瘍を予防又は治療するための薬物の調製における抗cd47抗体と抗cd20抗体の組み合わせの使用
CN114685663B (zh) 一种抗胆固醇依赖性细胞溶素的抗体及其应用